Cellular prognostic markers in hepatitis-related hepatocellular carcinoma

Infect Agent Cancer. 2018 Mar 27:13:10. doi: 10.1186/s13027-018-0183-8. eCollection 2018.


Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and accounts for about 6% of all new cancers diagnosed worldwide. Moreover, it is the third and the fifth leading cause of death from cancer in men and women, respectively. HBV and HCV chronic infection is the main risk factor for HCC. A range of therapies are used in the management of HCC according to the extent and severity of liver disease. In this perspective, evaluation of prognosis represents a crucial step for proper management of HCC patients. However, the clinical outcome can be significantly different in HCC patients within the same stage of disease. Therefore, many efforts have been made to define new parameters with more precise prognostic value, and the search for HCC prognostic markers is gaining momentum. The present review aims at providing an update on cellular prognostic markers for HCC.

Keywords: Cellular prognostic markers; Hepatocellular carcinoma; Immunoscore.

Publication types

  • Review